Advancing Treatment Strategies: The Role of Bispecific Antibodies in Lymphoma

Celeste Bello, MD, Moffitt Cancer Center, Tampa, FL
Recorded on November 21, 2024
Celeste Bello, MD
Senior Member, Department of Malignant Hematology
Moffitt Cancer Center
Tampa, FL
Join us as we dive into bispecific antibodies with Dr. Celeste Bello from Moffitt Cancer Center, exploring their mechanisms of action, current indications in lymphoma, and strategies for patient selection and administration. Dr. Bello also discusses side effects, management strategies, and emerging trends in bispecific therapies. Tune in today to learn more! Feedback
Information
- Show
- FrequencyUpdated Semimonthly
- PublishedDecember 19, 2024 at 2:35 PM UTC
- Length26 min
- RatingClean